Hirotaka Miyai
Papers
3
Total Citations
30
H-Index
3
About
Hirotaka Miyai is a pioneering surgeon whose work is reshaping the landscape of minimally invasive gastrointestinal oncology. His research centers on the surgical management of rectal and gastric cancers, with a particular focus on optimizing robotic and laparoscopic techniques to improve patient outcomes. Dr. Miyai’s major contributions include clarifying the indications for lateral lymph node dissection in patients with small rectal neuroendocrine tumors (NETs), a controversial area where he provides critical guidance for balancing oncologic safety with surgical morbidity. His 2021 case report and review on this topic has garnered 14 citations, underscoring its influence on clinical decision-making. Demonstrating his commitment to advancing surgical efficiency, Dr. Miyai’s 2023 propensity score-matched analysis comparing solo robot-assisted gastrectomy to laparoscopic gastrectomy for gastric cancer (13 citations) provides compelling evidence for the feasibility and potential benefits of robotic solo surgery. He has also contributed to the literature on rare conditions, such as a case report on robotic resection of diffuse cavernous hemangioma of the rectum. Through these works, Dr. Miyai is helping to define the future of precision, minimally invasive surgery for complex gastrointestinal diseases.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3